je.st
news
Merck expects no writedowns for Zetia, Vytorin cholesterol drugs
2014-11-11 04:01:13| Biotech - Topix.net
Merck & Co on Monday said long-awaited data from an 18,000-patient trial suggest the company will not have to write down the value of its blockbuster Zetia and Vytorin cholesterol drugs. "The company has determined that the Zetia and Vytorin intangible assets are not impaired," the No.
Tags: drugs
expects
cholesterol
merck
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||